ZYNERBA PHARMACEUTICALS, INC. Accrued Salaries, Current
ZYNERBA PHARMACEUTICALS, INC. had Accrued Salaries, Current of $1.49 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Accrued Liabilities, Current
us-gaap:AccruedSalariesCurrent · last filed 2023-08-14
- 2023-06-30: Accrued Salaries, Current $1.49M.
- 2023-03-31: Accrued Salaries, Current $997.85K.
- 2022-12-31: Accrued Salaries, Current $2.02M.
- 2022-09-30: Accrued Salaries, Current $2.01M.
| Period end | Accrued Salaries, Current |
|---|---|
| 2023-06-30 | $1.49M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $997.85K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.02M 10-Q · filed 2023-08-14 |
| 2022-09-30 | $2.01M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.68M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $913.92K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $2.41M 10-K · filed 2023-03-28 |
| 2021-09-30 | $2.10M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.64M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $938.56K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.93M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.89M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.50M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $897.67K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.34M 10-K · filed 2021-03-10 |
| 2019-09-30 | $1.89M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.41M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $846.27K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $2.19M 10-K · filed 2020-03-10 |
| 2018-09-30 | $1.79M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.41M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $685.97K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.50M 10-K · filed 2019-03-11 |
| 2017-09-30 | $1.17M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $930.42K 10-Q · filed 2017-08-01 |
| 2017-03-31 | $443.75K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $1.35M 10-K · filed 2018-03-12 |
| 2016-09-30 | $892.12K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $636.09K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $357.90K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $1.05M 10-K · filed 2017-03-27 |
| 2015-09-30 | $407.44K 10-Q · filed 2015-11-12 |
| 2014-12-31 | $37.05K 10-K · filed 2016-03-14 |